Themis Bioscience appoint Dr Philippe Dro and Dr Christian Mandl
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.